Ibnsina signs import and distribution agreement with Mundi Pharma

Ibnsina Pharma has signed an agreement with US multinational Mundi Pharma to import and distribute their products in Egypt, the company said in a statement (pdf). Mundi’s product range covers six therapeutic areas including oncology, respiratory, ophthalmology, pain, specialty care, and consumer health. Ibnsina expects revenues from the partnership to reach EGP 120 mn by the end of 2020. The Egyptian pharma company signed a similar agreement in September with Swiss firm Roche, which will see it import and distribute 40 products in Egypt.